Esperion Therapeutics IncNASDAQ:ESPR
- LAST PRICE1.5800
- TODAY'S CHANGE (%)0.0800 (5.3333%)
- Bid / Lots1.5500/ 74
- Ask / Lots1.6000/ 200
- Open / Previous Close1.5100 / 1.5000
- Day Range
- 52 Week Range
- Volume2,159,149
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ESPR |
|---|---|---|
| 09:32 ET | 38618 | 1.515 |
| 09:33 ET | 6440 | 1.52 |
| 09:35 ET | 300 | 1.52 |
| 09:37 ET | 2997 | 1.52 |
| 09:39 ET | 5442 | 1.51 |
| 09:42 ET | 4654 | 1.52 |
| 09:44 ET | 830 | 1.5192 |
| 09:46 ET | 34843 | 1.515 |
| 09:48 ET | 332 | 1.5199 |
| 09:50 ET | 36302 | 1.51 |
| 09:51 ET | 21382 | 1.525 |
| 09:53 ET | 9195 | 1.535 |
| 09:55 ET | 8541 | 1.54 |
| 09:57 ET | 21593 | 1.555 |
| 10:00 ET | 9578 | 1.5598 |
| 10:02 ET | 18099 | 1.57 |
| 10:04 ET | 23568 | 1.57 |
| 10:06 ET | 16041 | 1.575 |
| 10:08 ET | 12717 | 1.5738 |
| 10:09 ET | 2450 | 1.5775 |
| 10:11 ET | 14696 | 1.56 |
| 10:13 ET | 100 | 1.565 |
| 10:15 ET | 9325 | 1.58 |
| 10:18 ET | 23133 | 1.5693 |
| 10:20 ET | 67542 | 1.565 |
| 10:22 ET | 37503 | 1.5704 |
| 10:24 ET | 6182 | 1.5875 |
| 10:26 ET | 11564 | 1.58 |
| 10:27 ET | 64344 | 1.595 |
| 10:29 ET | 16129 | 1.5908 |
| 10:31 ET | 8131 | 1.58 |
| 10:33 ET | 6481 | 1.59 |
| 10:36 ET | 10470 | 1.59 |
| 10:38 ET | 17683 | 1.585 |
| 10:40 ET | 5387 | 1.58 |
| 10:42 ET | 2762 | 1.59 |
| 10:44 ET | 1800 | 1.585 |
| 10:45 ET | 1645 | 1.59 |
| 10:47 ET | 63456 | 1.585 |
| 10:49 ET | 26980 | 1.57 |
| 10:51 ET | 46683 | 1.575 |
| 10:54 ET | 78795 | 1.57 |
| 10:56 ET | 27588 | 1.575 |
| 10:58 ET | 38361 | 1.585 |
| 11:00 ET | 900 | 1.5875 |
| 11:02 ET | 2000 | 1.585 |
| 11:03 ET | 1757 | 1.585 |
| 11:05 ET | 60715 | 1.575 |
| 11:07 ET | 3811 | 1.575 |
| 11:09 ET | 3100 | 1.575 |
| 11:12 ET | 4004 | 1.5798 |
| 11:14 ET | 681 | 1.5775 |
| 11:16 ET | 7604 | 1.575 |
| 11:18 ET | 12679 | 1.57 |
| 11:20 ET | 4747 | 1.565 |
| 11:21 ET | 17663 | 1.5775 |
| 11:23 ET | 5567 | 1.58 |
| 11:25 ET | 19467 | 1.57 |
| 11:27 ET | 200 | 1.57 |
| 11:30 ET | 12651 | 1.5875 |
| 11:32 ET | 12550 | 1.585 |
| 11:34 ET | 64780 | 1.5875 |
| 11:36 ET | 3100 | 1.5801 |
| 11:38 ET | 1632 | 1.585 |
| 11:39 ET | 3560 | 1.585 |
| 11:41 ET | 1000 | 1.585 |
| 11:43 ET | 6757 | 1.585 |
| 11:45 ET | 11293 | 1.585 |
| 11:48 ET | 40461 | 1.58 |
| 11:50 ET | 13255 | 1.58 |
| 11:52 ET | 7416 | 1.58 |
| 11:54 ET | 1587 | 1.58 |
| 11:56 ET | 27596 | 1.575 |
| 11:57 ET | 400 | 1.57 |
| 11:59 ET | 1600 | 1.5775 |
| 12:01 ET | 1025 | 1.575 |
| 12:03 ET | 500 | 1.58 |
| 12:06 ET | 600 | 1.58 |
| 12:08 ET | 25286 | 1.57 |
| 12:10 ET | 17400 | 1.56 |
| 12:12 ET | 9767 | 1.56 |
| 12:14 ET | 5032 | 1.56 |
| 12:15 ET | 61441 | 1.555 |
| 12:17 ET | 30394 | 1.56 |
| 12:19 ET | 5100 | 1.56 |
| 12:21 ET | 1300 | 1.56 |
| 12:24 ET | 200 | 1.56 |
| 12:26 ET | 700 | 1.56 |
| 12:28 ET | 14810 | 1.56 |
| 12:30 ET | 2600 | 1.555 |
| 12:32 ET | 1581 | 1.56 |
| 12:33 ET | 300 | 1.56 |
| 12:35 ET | 500 | 1.56 |
| 12:37 ET | 7134 | 1.56 |
| 12:39 ET | 300 | 1.57 |
| 12:42 ET | 800 | 1.57 |
| 12:44 ET | 200 | 1.57 |
| 12:46 ET | 20865 | 1.5775 |
| 12:48 ET | 700 | 1.58 |
| 12:50 ET | 1020 | 1.575 |
| 12:51 ET | 1300 | 1.57 |
| 12:53 ET | 400 | 1.58 |
| 12:55 ET | 400 | 1.575 |
| 12:57 ET | 15252 | 1.575 |
| 01:00 ET | 500 | 1.58 |
| 01:02 ET | 2753 | 1.58 |
| 01:04 ET | 10300 | 1.58 |
| 01:06 ET | 1300 | 1.58 |
| 01:08 ET | 200 | 1.58 |
| 01:09 ET | 5856 | 1.58 |
| 01:11 ET | 600 | 1.58 |
| 01:13 ET | 900 | 1.58 |
| 01:15 ET | 1788 | 1.58 |
| 01:18 ET | 2500 | 1.5781 |
| 01:20 ET | 2600 | 1.58 |
| 01:22 ET | 500 | 1.58 |
| 01:24 ET | 2757 | 1.58 |
| 01:26 ET | 5100 | 1.58 |
| 01:27 ET | 4700 | 1.58 |
| 01:29 ET | 500 | 1.58 |
| 01:31 ET | 9424 | 1.5788 |
| 01:33 ET | 1086 | 1.575 |
| 01:36 ET | 8053 | 1.575 |
| 01:38 ET | 500 | 1.575 |
| 01:40 ET | 1100 | 1.58 |
| 01:42 ET | 400 | 1.58 |
| 01:44 ET | 1694 | 1.58 |
| 01:45 ET | 45609 | 1.575 |
| 01:47 ET | 400 | 1.58 |
| 01:49 ET | 9189 | 1.575 |
| 01:51 ET | 454 | 1.58 |
| 01:54 ET | 900 | 1.58 |
| 01:56 ET | 2820 | 1.58 |
| 01:58 ET | 775 | 1.58 |
| 02:00 ET | 1600 | 1.5797 |
| 02:02 ET | 2900 | 1.5709 |
| 02:03 ET | 31466 | 1.565 |
| 02:05 ET | 14523 | 1.56 |
| 02:07 ET | 4625 | 1.5595 |
| 02:09 ET | 6055 | 1.56 |
| 02:12 ET | 600 | 1.555 |
| 02:14 ET | 1300 | 1.5593 |
| 02:16 ET | 4925 | 1.56 |
| 02:18 ET | 3400 | 1.56 |
| 02:20 ET | 1650 | 1.56 |
| 02:21 ET | 1300 | 1.55 |
| 02:23 ET | 5100 | 1.56 |
| 02:25 ET | 3500 | 1.56 |
| 02:27 ET | 300 | 1.56 |
| 02:30 ET | 900 | 1.56 |
| 02:32 ET | 57644 | 1.54 |
| 02:34 ET | 19487 | 1.545 |
| 02:36 ET | 100 | 1.55 |
| 02:38 ET | 3096 | 1.5501 |
| 02:39 ET | 300 | 1.555 |
| 02:41 ET | 300 | 1.555 |
| 02:43 ET | 700 | 1.555 |
| 02:45 ET | 300 | 1.555 |
| 02:48 ET | 2600 | 1.555 |
| 02:50 ET | 2000 | 1.555 |
| 02:52 ET | 2000 | 1.56 |
| 02:54 ET | 1274 | 1.555 |
| 02:56 ET | 2100 | 1.56 |
| 02:57 ET | 1456 | 1.56 |
| 02:59 ET | 1150 | 1.56 |
| 03:01 ET | 18352 | 1.56 |
| 03:03 ET | 4790 | 1.56 |
| 03:06 ET | 3250 | 1.55 |
| 03:08 ET | 21923 | 1.57 |
| 03:10 ET | 1590 | 1.565 |
| 03:12 ET | 700 | 1.57 |
| 03:14 ET | 500 | 1.57 |
| 03:15 ET | 2900 | 1.56 |
| 03:17 ET | 1950 | 1.565 |
| 03:19 ET | 2100 | 1.57 |
| 03:21 ET | 800 | 1.57 |
| 03:24 ET | 3141 | 1.57 |
| 03:26 ET | 700 | 1.57 |
| 03:28 ET | 900 | 1.565 |
| 03:30 ET | 9163 | 1.57 |
| 03:32 ET | 4309 | 1.57 |
| 03:33 ET | 3000 | 1.57 |
| 03:35 ET | 800 | 1.57 |
| 03:37 ET | 1599 | 1.57 |
| 03:39 ET | 5935 | 1.565 |
| 03:42 ET | 15363 | 1.555 |
| 03:44 ET | 17264 | 1.565 |
| 03:46 ET | 200 | 1.57 |
| 03:48 ET | 46609 | 1.56 |
| 03:50 ET | 3057 | 1.57 |
| 03:51 ET | 2500 | 1.57 |
| 03:53 ET | 10212 | 1.565 |
| 03:55 ET | 39579 | 1.57 |
| 03:57 ET | 13917 | 1.58 |
| 04:00 ET | 69493 | 1.58 |
Nov 13, 2023
DJ Esperion Therapeutics Price Target Maintained With a $22.00/Share by HC Wainwright & Co., from 11:28AM ET on Monday Nov 13, 2023 by Dow Jones
11:28AM ET on Monday Nov 13, 2023 by Dow JonesEsperion Presents CLEAR Outcomes Analysis of Inflammation as Predictor of Cardiovascular Risk at American Heart Association Scientific Sessions 2023, from 10:30AM ET on Monday Nov 13, 2023 by Dow Jones
10:30AM ET on Monday Nov 13, 2023 by Dow Jones
Nov 11, 2023
Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023, from 11:00AM ET on Saturday Nov 11, 2023 by Dow Jones
11:00AM ET on Saturday Nov 11, 2023 by Dow Jones
Nov 9, 2023
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), from 4:30PM ET on Thursday Nov 09, 2023 by Dow Jones
4:30PM ET on Thursday Nov 09, 2023 by Dow Jones
Nov 7, 2023
DJ Esperion Therapeutics Is Maintained at Buy by Needham, from 3:40PM ET on Tuesday Nov 07, 2023 by Dow Jones
3:40PM ET on Tuesday Nov 07, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Esperion Therapeutics Inc | 170.6M | -0.7x | --- |
OptiNose Inc | 138.1M | -3.2x | --- |
Journey Medical Corp | 76.2M | -8.0x | --- |
Rockwell Medical Inc | 47.6M | -3.0x | --- |
Nektar Therapeutics | 99.2M | -0.3x | --- |
Aquestive Therapeutics Inc | 137.5M | -8.6x | --- |
Company Information
Esperion Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). The Company's bempedoic acid and the bempedoic acid / ezetimibe combination tablets are oral, once-daily, non-statin, LDL-C lowering medicines for patients with atherosclerotic cardiovascular disease (ASCVD), or heterozygous familial hypercholesterolemia (HeFH). The Company's products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. Its NEXLETOL is an ATP Citrate Lyase (ACL), inhibitor that lowers LDL-C by reducing cholesterol biosynthesis and up-regulating the LDL receptors. Its NEXLIZET and NUSTENDI contains bempedoic acid and ezetimibe and lowers elevated LDL-C through complementary mechanisms of action by inhibiting cholesterol synthesis in the liver and absorption in the intestine.
Contact Information
- Headquarters
- 601 21St Street, Suite 300VERO BEACH, FL, United States 32960
- Phone
- 772-453-2770
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- J. Martin Carroll
- President, Chief Executive Officer, Director
- Sheldon Koenig
- Chief Financial Officer
- Benjamin Halladay
- General Counsel
- Benjamin Looker
- Chief Medical Officer
- JoAnne Foody
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $170.6M |
|---|---|
Revenue (TTM) | $102.9M |
Shares Outstanding | 113.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.52 |
EPS | $-2.37 |
Book Value | $-4.34 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 1.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -151.32% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
